Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick M Sexton

Showing results (241-250 of 301) with videos related to

Pageof 31
Sort By:
Science (New York, N.Y.)|February 19, 2021
Structure and dynamics of the CGRP receptor in apo and peptide-bound formsTracy M Josephs, Matthew J Belousoff, Yi-Lynn Liang, et al.
European Journal of Pharmacology|April 14, 2018
Vascular and molecular pharmacology of the metabolically stable CGRP analogue, SAXMajid Sheykhzade, Bahareh Abdolalizadeh, Cassandra Koole, et al.
Bioinformatics (Oxford, England)|September 11, 2019
Automatic local resolution-based sharpening of cryo-EM mapsErney Ramírez-Aportela, Jose Luis Vilas, Alisa Glukhova, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 20, 2025
Structural basis of modified ligand selectivity from N-terminal PAC1R alternative splicingJessica J Lu, Giuseppe Deganutti, Miaomiao Li, et al.
Biochemical Pharmacology|February 19, 2018
Extracellular loops 2 and 3 of the calcitonin receptor selectively modify agonist binding and efficacyEmma Dal Maso, Yue Zhu, Vi Pham, et al.
Neuropharmacology|October 26, 2018
Drug-receptor kinetics and sigma-1 receptor affinity differentiate clinically evaluated histamine H<sub>3</sub> receptor antagonistsDarren M Riddy, Anna E Cook, David M Shackleford, et al.
Science Signaling|November 15, 2022
M<sub>1</sub> muscarinic receptor activation reduces the molecular pathology and slows the progression of prion-mediated neurodegenerative diseaseLouis Dwomoh, Mario Rossi, Miriam Scarpa, et al.
ACS Chemical Neuroscience|December 15, 2018
6-Phenylpyrimidin-4-ones as Positive Allosteric Modulators at the M<sub>1</sub> mAChR: The Determinants of Allosteric ActivityManuela Jörg, Emma T van der Westhuizen, Elham Khajehali, et al.
Journal of the American Chemical Society|August 17, 2019
O-GlcNAc Engineering of GPCR Peptide-Agonists Improves Their Stability and in Vivo ActivityPaul M Levine, Aaron T Balana, Emmanuel Sturchler, et al.
Biochemical Pharmacology|August 2, 2021
Insights into agonist-elicited activation of the human glucose-dependent insulinotropic polypeptide receptorElita Yuliantie, Wijnand J C van der Velden, Viktorija Labroska, et al.
Pageof 31

Showing results (241-250 of 301) with videos related to

Sort By:
Pageof 31
Science (New York, N.Y.)|February 19, 2021
Structure and dynamics of the CGRP receptor in apo and peptide-bound formsTracy M Josephs, Matthew J Belousoff, Yi-Lynn Liang, et al.
European Journal of Pharmacology|April 14, 2018
Vascular and molecular pharmacology of the metabolically stable CGRP analogue, SAXMajid Sheykhzade, Bahareh Abdolalizadeh, Cassandra Koole, et al.
Bioinformatics (Oxford, England)|September 11, 2019
Automatic local resolution-based sharpening of cryo-EM mapsErney Ramírez-Aportela, Jose Luis Vilas, Alisa Glukhova, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 20, 2025
Structural basis of modified ligand selectivity from N-terminal PAC1R alternative splicingJessica J Lu, Giuseppe Deganutti, Miaomiao Li, et al.
Biochemical Pharmacology|February 19, 2018
Extracellular loops 2 and 3 of the calcitonin receptor selectively modify agonist binding and efficacyEmma Dal Maso, Yue Zhu, Vi Pham, et al.
Neuropharmacology|October 26, 2018
Drug-receptor kinetics and sigma-1 receptor affinity differentiate clinically evaluated histamine H<sub>3</sub> receptor antagonistsDarren M Riddy, Anna E Cook, David M Shackleford, et al.
Science Signaling|November 15, 2022
M<sub>1</sub> muscarinic receptor activation reduces the molecular pathology and slows the progression of prion-mediated neurodegenerative diseaseLouis Dwomoh, Mario Rossi, Miriam Scarpa, et al.
ACS Chemical Neuroscience|December 15, 2018
6-Phenylpyrimidin-4-ones as Positive Allosteric Modulators at the M<sub>1</sub> mAChR: The Determinants of Allosteric ActivityManuela Jörg, Emma T van der Westhuizen, Elham Khajehali, et al.
Journal of the American Chemical Society|August 17, 2019
O-GlcNAc Engineering of GPCR Peptide-Agonists Improves Their Stability and in Vivo ActivityPaul M Levine, Aaron T Balana, Emmanuel Sturchler, et al.
Biochemical Pharmacology|August 2, 2021
Insights into agonist-elicited activation of the human glucose-dependent insulinotropic polypeptide receptorElita Yuliantie, Wijnand J C van der Velden, Viktorija Labroska, et al.
Pageof 31